Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
1
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
0 competitors in Advanced Gastroenteropancreatic Neuroendocrine Tumor
View Full LandscapeTarget Indication
Advanced Gastroenteropancreatic Neuroendocrine Tumor
Clinical Trial
NCT05884255Last updated: 1/6/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Deqtynet
Positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine neoplasms (NENs).